QP ExCELs Sentus QP-Extended CRT Evaluation with Quadripolar Left Ventricular Leads

November 22, 2017

  • Clinical Trial Information

    Trial Contact: Peisner, Pamela

    Trial Phone: 321.843.1037

  • IRB No: 16.006.01

    Protocol Abbrev: QP ExCELS

    Principal Investigator: Luis Isaac Garcia, MD

    Sub Investigators: Filart, Roland MD; Guguchev, Pavel MD; Duran, Aurelio MD

    Phase: Device: Significant Risk

    Age Group: Adult

    Treatment: Procedural

    Applicable Disease Sites: Heart Failure

    Therapies Involved: Devices

    ClinicalTrials.gov ID: NCT02290028

  • Objective

    Confirm safety and efficacy of the BIOTRONIK left ventricular leads Sentus OTW QP L and Sentus OTW QP S to satisfy FDA requirements for regulatory approval of the leads in the US

  • Key Eligibility

    Heart Failure